Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP636578.RAlShgTwGlmvcN1UF69coKdi86senjpalfhgzz0SkYwJE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP636578.RAlShgTwGlmvcN1UF69coKdi86senjpalfhgzz0SkYwJE130_assertion type Assertion NP636578.RAlShgTwGlmvcN1UF69coKdi86senjpalfhgzz0SkYwJE130_head.
- NP636578.RAlShgTwGlmvcN1UF69coKdi86senjpalfhgzz0SkYwJE130_assertion description "[The high potency, significant gene induction, excellent PK profiles, and good in vivo efficacies in three animal models may render compound 24 as a valuable pharmacological tool in elucidating the complex roles of PPARalpha/delta dual agonists and as a potential treatment of the metabolic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP636578.RAlShgTwGlmvcN1UF69coKdi86senjpalfhgzz0SkYwJE130_provenance.
- NP636578.RAlShgTwGlmvcN1UF69coKdi86senjpalfhgzz0SkYwJE130_assertion evidence source_evidence_literature NP636578.RAlShgTwGlmvcN1UF69coKdi86senjpalfhgzz0SkYwJE130_provenance.
- NP636578.RAlShgTwGlmvcN1UF69coKdi86senjpalfhgzz0SkYwJE130_assertion SIO_000772 17608467 NP636578.RAlShgTwGlmvcN1UF69coKdi86senjpalfhgzz0SkYwJE130_provenance.
- NP636578.RAlShgTwGlmvcN1UF69coKdi86senjpalfhgzz0SkYwJE130_assertion wasDerivedFrom befree-20150227 NP636578.RAlShgTwGlmvcN1UF69coKdi86senjpalfhgzz0SkYwJE130_provenance.
- NP636578.RAlShgTwGlmvcN1UF69coKdi86senjpalfhgzz0SkYwJE130_assertion wasGeneratedBy ECO_0000203 NP636578.RAlShgTwGlmvcN1UF69coKdi86senjpalfhgzz0SkYwJE130_provenance.